Umifenovir did not show superior clinical outcomes when added to Favipiravir treatment. The trial did not meet key end-points ... Oct 21
Vir Biotechnology, Inc. and GlaxoSmithKline today announced the global expansion to Phase 3 of the COMET-ICE study for the early treatment of COVID-19 ... Oct 06
-Advertisements-